Slides: Integrating EPA based therapy in the management of residual CV riskSlides (presentation) - Sep. 13, 2021 - Prof. Ph. Gabriel Steg, MD - Paris, France - CME symposium held during ESC Congress 2021
Slides as educational service to PACE members and meeting participants.
This lecture by Prof. Ph. Gabriel Steg was part of a EBAC-accredited symposium "Tackling residual risk beyond LDL-c therapy: The emerging role of EPA & triglycerides" held during ESC Congress 2021.